Income Tax Benefit (Expense) (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Mar. 31, 2019 |
|
| Income Tax Disclosure [Abstract] | |||||
| Income tax benefit (expense) | $ (3,761) | $ 11,203 | $ (19,057) | $ (16,457) | |
| Tax benefit connection with the reversal of substantially all of valuation allowance on net operating loss carryforwards | $ 35,700 | ||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|